Literature DB >> 15582124

Epidemiology of liver disease in cystic fibrosis: a longitudinal study.

Thierry Lamireau1, Sylvie Monnereau, Steven Martin, Jacques-Edouard Marcotte, Maria Winnock, Fernando Alvarez.   

Abstract

BACKGROUND/AIMS: To describe the prevalence of liver disease in a cohort of 241 cystic fibrosis (CF) patients.
METHODS: 241 CF patients were followed-up every 3 months with clinical and biological assessment, and every year with ultrasonography of the liver. The presence of liver disease was studied using a multivariate Cox's regression analysis including variables such as history of meconium ileus, pulmonary function, pancreatic insufficiency and CFTR gene mutations.
RESULTS: The prevalence of liver disease was 18, 29, and 41% after 2, 5 and 12 years, respectively, and did not increase thereafter. In multivariate analysis, the probability of liver disease was independently associated with history of meconium ileus (P = 0.001) and pancreatic insufficiency (P = 0.004). CFTR mutations and severity of pulmonary disease were not associated with liver disease. Cirrhosis occurred in 19 (7.8%) patients at a median age of 10 years, and liver transplantation was required in five patients.
CONCLUSIONS: This study shows that CF related-liver disease occurs mainly in the first decade of life with a prevalence of 41% of patients at 12 years of age. A history of meconium ileus and pancreatic insufficiency are predictive of liver disease. Preventive treatment with ursodesoxycholic acid could be considered in patients with meconium ileus.

Entities:  

Mesh:

Year:  2004        PMID: 15582124     DOI: 10.1016/j.jhep.2004.08.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  43 in total

Review 1.  Hepatic Manifestations of Cystic Fibrosis.

Authors:  Sasan Sakiani; David E Kleiner; Theo Heller; Christopher Koh
Journal:  Clin Liver Dis       Date:  2019-02-21       Impact factor: 6.126

2.  Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.

Authors:  Matthew D Sadler; Pam Crotty; Linda Fatovich; Stephanie Wilson; Harvey R Rabin; Robert P Myers
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04

3.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

4.  Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes.

Authors:  Dongning He; Teresa W Wilborn; Josie L Falany; Li Li; Charles N Falany
Journal:  Biochim Biophys Acta       Date:  2008-09-11

5.  Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.

Authors:  Wen Ye; Michael R Narkewicz; Daniel H Leung; Wikrom Karnsakul; Karen F Murray; Estella M Alonso; John C Magee; Sarah Jane Schwarzenberg; Alexander Weymann; Jean P Molleston
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

6.  A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene.

Authors:  Zhiqiang Fan; Iuri Viotti Perisse; Calvin U Cotton; Misha Regouski; Qinggang Meng; Chaim Domb; Arnaud J Van Wettere; Zhongde Wang; Ann Harris; Kenneth L White; Irina A Polejaeva
Journal:  JCI Insight       Date:  2018-10-04

Review 7.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Soe Moe; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

8.  Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis.

Authors:  Daniel H Leung; Wen Ye; Jean P Molleston; Alexander Weymann; Simon Ling; Shruti M Paranjape; Rene Romero; Sara Jane Schwarzenberg; Joseph Palermo; Estella M Alonso; Karen F Murray; Bruce C Marshall; Averell H Sherker; Marilyn J Siegel; Rajesh Krishnamurthy; Roger Harned; Boaz Karmazyn; John C Magee; Michael R Narkewicz
Journal:  J Pediatr       Date:  2015-08-05       Impact factor: 4.406

9.  Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.

Authors:  Jaclyn R Stonebraker; Chee Y Ooi; Rhonda G Pace; Harriet Corvol; Michael R Knowles; Peter R Durie; Simon C Ling
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-05       Impact factor: 11.382

10.  Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children.

Authors:  L Monti; M Manco; C Lo Zupone; A Latini; M L D'Andrea; F Alghisi; V Lucidi; P Tomà; L Bonomo
Journal:  Radiol Med       Date:  2012-09-17       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.